IT201900022881A1 - Budesonide per uso oftalmico in un metodo di trattamento dell’occhio - Google Patents

Budesonide per uso oftalmico in un metodo di trattamento dell’occhio

Info

Publication number
IT201900022881A1
IT201900022881A1 IT102019000022881A IT201900022881A IT201900022881A1 IT 201900022881 A1 IT201900022881 A1 IT 201900022881A1 IT 102019000022881 A IT102019000022881 A IT 102019000022881A IT 201900022881 A IT201900022881 A IT 201900022881A IT 201900022881 A1 IT201900022881 A1 IT 201900022881A1
Authority
IT
Italy
Prior art keywords
budesonide
treatment method
ophthalmic use
eye treatment
ophthalmic
Prior art date
Application number
IT102019000022881A
Other languages
English (en)
Inventor
Luciano Marcelloni
Federico Bertocchi
Original Assignee
Ntc Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ntc Srl filed Critical Ntc Srl
Priority to IT102019000022881A priority Critical patent/IT201900022881A1/it
Priority to EP20829208.6A priority patent/EP4069249A1/en
Priority to MX2022006523A priority patent/MX2022006523A/es
Priority to CA3163198A priority patent/CA3163198A1/en
Priority to US17/777,964 priority patent/US20220409633A1/en
Priority to PCT/IB2020/061444 priority patent/WO2021111358A1/en
Priority to CN202080083485.9A priority patent/CN114746098A/zh
Priority to IL293376A priority patent/IL293376A/en
Priority to AU2020394893A priority patent/AU2020394893A1/en
Publication of IT201900022881A1 publication Critical patent/IT201900022881A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
IT102019000022881A 2019-12-03 2019-12-03 Budesonide per uso oftalmico in un metodo di trattamento dell’occhio IT201900022881A1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT102019000022881A IT201900022881A1 (it) 2019-12-03 2019-12-03 Budesonide per uso oftalmico in un metodo di trattamento dell’occhio
EP20829208.6A EP4069249A1 (en) 2019-12-03 2020-12-03 Composition comprising budesonide for ophthalmic use
MX2022006523A MX2022006523A (es) 2019-12-03 2020-12-03 Composicion que comprende budesonida para uso oftalmico.
CA3163198A CA3163198A1 (en) 2019-12-03 2020-12-03 Composition comprising budesonide for ophthalmic use
US17/777,964 US20220409633A1 (en) 2019-12-03 2020-12-03 Composition comprising budesonide for ophthalmic use
PCT/IB2020/061444 WO2021111358A1 (en) 2019-12-03 2020-12-03 Composition comprising budesonide for ophthalmic use
CN202080083485.9A CN114746098A (zh) 2019-12-03 2020-12-03 用于眼科的包含布地奈德的组合物
IL293376A IL293376A (en) 2019-12-03 2020-12-03 A preparation containing budesonide for ophthalmic use
AU2020394893A AU2020394893A1 (en) 2019-12-03 2020-12-03 Composition comprising budesonide for ophthalmic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000022881A IT201900022881A1 (it) 2019-12-03 2019-12-03 Budesonide per uso oftalmico in un metodo di trattamento dell’occhio

Publications (1)

Publication Number Publication Date
IT201900022881A1 true IT201900022881A1 (it) 2021-06-03

Family

ID=70154897

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000022881A IT201900022881A1 (it) 2019-12-03 2019-12-03 Budesonide per uso oftalmico in un metodo di trattamento dell’occhio

Country Status (1)

Country Link
IT (1) IT201900022881A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
US20110123518A1 (en) * 2003-12-31 2011-05-26 Cydex Pharmaceuticals, Inc. Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
RU2014122958A (ru) * 2014-06-06 2015-12-20 Илья Александрович Марков Офтальмологическая композиция, обладающая противовоспалительным и противоаллергическим действием, для лечения конъюктивитов и блефаритов при местном применении
WO2019170848A1 (en) * 2018-03-09 2019-09-12 Panoptes Pharma Ges.M.B.H. Ophthalmic formulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123518A1 (en) * 2003-12-31 2011-05-26 Cydex Pharmaceuticals, Inc. Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
RU2014122958A (ru) * 2014-06-06 2015-12-20 Илья Александрович Марков Офтальмологическая композиция, обладающая противовоспалительным и противоаллергическим действием, для лечения конъюктивитов и блефаритов при местном применении
WO2019170848A1 (en) * 2018-03-09 2019-09-12 Panoptes Pharma Ges.M.B.H. Ophthalmic formulation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 51333-22-3
ELISABET WIESLANDER ET AL.: "Pharmacologic Importance of the reversible fatty acid Anjugation of Budesonide studied in a Rat Cell Line in vitro", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, vol. 19, 1998, pages 477 - 484
JENDBRO ET AL.: "Pharmacokinetics of budesonide and its major ester metabolite after halation and labor administration of budesonide in the rat", DRUG METABOLISM AND DISPOSITION, THE AMERICAN SOCIETY OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 29, no. 5, 1998
KOMPELLA U B ET AL: "SUBCONJUNCTIVAL NANO- AND MICROPARTICLES SUSTAIN RETINAL DELIVERY OF BUDESONIDE, A CORTICOSTEROID CAPABLE OF INHIBITING VEGF EXPRESSION", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY|, US, vol. 44, no. 3, 1 March 2003 (2003-03-01), pages 1192 - 1201, XP008042452, ISSN: 0146-0404, DOI: 10.1167/IOVS.02-0791 *

Similar Documents

Publication Publication Date Title
IL277333A (en) Methods for treating eye diseases
HUE058931T2 (hu) Pilokarpin hidroklorid alkalmazása presbyopia kezelésére
CY1121806T1 (el) Ιμιδαζοπυραζινονες ως αναστολεις pde1
IL276918A (en) Ophthalmic formulation
IL282447A (en) Methods and preparations for healing eye cell
ZA201803164B (en) An ophthalmic progressive addition lens for a myopic or emmetropic presbyopic wearer; method for providing such a lens
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
IL284344A (en) Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
EP3310353A4 (en) COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF EYE DISEASES
GB2581651B (en) Opthalmoscope using natural pupil dilation
GB2556599B (en) Method and apparatus for manufacturing ophthalmic lenses
IT201900022881A1 (it) Budesonide per uso oftalmico in un metodo di trattamento dell’occhio
SG11202012473UA (en) Ophthalmic compositions and methods for the treatment of eye disorders
IL289436A (en) Methods for treating eye diseases
ZA202107235B (en) Compositions and methods for treating ocular disease
EP3468446A4 (en) OPHTHALMOLOGICAL ULTRASONIC BIOMICROSCOPE (UBM) DEVICE
IL271315A (en) A method for determining the high accuracy of the pupil diameter and a compatible device
SG11202110659SA (en) Method for treating ocular diseases
IT201700006360A1 (it) Composizione per uso oftalmico
IL283497A (en) Methods, preparations and kits for the treatment of eye diseases
ZA202109745B (en) Improved ophthalmic apparatus
IT201900022029A1 (it) Formulazioni oftalmiche
IT201900022860A1 (it) Composizione comprendente budesonide per uso oftalmico
EP3706868A4 (en) METHOD OF INDUCING PUPIL DILATATION